Fakeeh Care
فقيه الطبيةTechnical Analysis & Signals
Fakieh Medical's stock shows an upward trend with clear support and resistance levels in the Saudi market.
Technical Analysis
The stock is currently trading at SAR 36.0, with an RSI of 55.4 indicating moderate strength. An upward trend is expected to continue, especially with the bullish_flag pattern that may support upward movement.
Support & Resistance Levels
The main support level for the stock is SAR 35.72, while resistance is at SAR 37.06. A breakout above the resistance level could signal a continuation of the upward trend.
Volume Analysis
Current trading volume is not mentioned, but an increase in volume is expected as the upward trend continues. Higher volume could enhance confidence in the stock's movement.
Fundamental Factors
The stock's price-to-earnings ratio is 27.7, indicating a relatively high valuation. The dividend yield at 0.84% may attract investors looking for steady income.
Risk Factors
There are potential risks related to fluctuations in the Saudi market and their impact on the stock's performance. It is important to monitor any changes in economic or political conditions that may affect the sector.
Recommendation
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. Investors are advised to conduct their own research before making any investment decisions.
Automated analysis is based on historical data and technical indicators and may not reflect future market conditions.
Financial Fundamentals
Price Data
Price Chart - Fakeeh Care
4017Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Within BandTrend Strength (ADX)
Moderate TrendFinancial Summary
Valuation
- Market Cap
- 8.28B
- P/E Ratio
- 27.70
- P/B Ratio
- 2.60
- EPS (Earnings/Share)
- 1.30
Profitability
- Revenue
- 3.09B
- Net Income
- 290.18M
- Return on Equity (ROE)
- +10.00%
- Shares Outstanding
- 230.00M
Balance Sheet
- Total Assets
- N/A
- Total Debt
- 1.18B
- Debt/Equity
- 0.33
- Free Float %
- +21.2%
Dividends & Margins
- Dividend Yield
- +0.84%
- Dividend/Share
- 0.30
- Book Value
- 13.85
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
2 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2024 | 2.79B +20.0% | 287.55M +2.8% | 5.32B +25.7% | 1.08B -52.4% | 1.25 +2.5% |
| 2023 | 2.33B | 279.60M | 4.23B | 2.26B | 1.22 |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
Fakeeh Care EGM approves employee share program
Tadawul-listed firms likely to announce dividends in March
Fakeeh Care signs SAR 218M long-term land lease pact in Jazan
Fakeeh Care signs SAR 97.3M land lease deal with Madinah Municipality
Fakeeh Care acquires 50.01% of Diagnostics Elite for SAR 70M
ANB Capital reviews Q4 2025 financials of four healthcare firms
AlJazira Capital issues Q4 2025 profit forecasts
Saudi healthcare sector in Q4 2025: Key events likely to impact performance
News source: Argaam (argaam.com)
Sector Comparison
| Symbol | Name | Price | Change% |
|---|---|---|---|
| 4013 | Dr. Sulaiman Al Habib | 224.60 SAR | |
| 4002 | Mouwasat | 66.50 SAR | |
| 4004 | Dallah Healthcare | 112.00 SAR | |
| 4017 | Fakeeh Care | 36.00 SAR | |
| 4018 | Almoosa | 129.50 SAR | |
| 4005 | CARE | 103.30 SAR | |
| 4019 | SMC Healthcare | 17.60 SAR | |
| 4007 | Alhammadi | 25.32 SAR |
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-05-11
Risk Assessment
Risk Factors
Average True Range 3.0% of stock price
Trading volume below average
P/E ratio 27.7
Debt-to-equity ratio 0.33
ADX indicator at 25
Stable fundamentals, low volatility, and good financial solvency
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is Fakeeh Care stock price today?
Fakeeh Care (4017) stock price today is 36.00 SAR, declining by -1.37% compared to the previous session close. The 52-week price range is between 27.20 SAR and 46.80 SAR.
2 What is Fakeeh Care stock valuation?
The automated analysis signal for Fakeeh Care is "Buy" with 70% confidence. The P/E ratio is 27.7. The P/B ratio is 2.60.
3 Is Fakeeh Care Shariah-compliant?
Yes, Fakeeh Care (4017) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are Fakeeh Care dividend distributions?
Fakeeh Care has a dividend yield of 0.84%, with an estimated annual dividend of 0.30 SAR per share.
5 What is Fakeeh Care weekly performance?
Fakeeh Care performance over different time periods: weekly change +3.75%, monthly +4.77%, and year-to-date +4.65%. The stock is currently trading with a volume of 81,020 shares.
6 What is the target level for Fakeeh Care?
According to automated analysis for Fakeeh Care: Short-term target (1-2 weeks): 37.50 SAR. Medium-term target (1-3 months): 40.00 SAR. Support level: 35.72 SAR. Resistance level: 37.06 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.